EONE DIAGNOMICS GENOME CENTER Co., Ltd. engages in the operation as a genomics company providing a range of clinical and consumer genetic services. The firm is equipped with cutting-edge genomics data analysis expertise. Its services include non-invasive prenatal diagnostic test, newborn genetic screening test, ophthalmology genetic test, and Direct-to-Consumer genetic test. The company was founded on May 6, 2013 and is headquartered in Incheon, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company